Sun pharma market cap surpasses SBI

Published on March 18, 2015 14:03:19 PM
Business
Drug major Sun Pharmaceutical Industries surpassed SBI in terms of market valuation.

Sun Pharma's market capitalisation (m-cap) increased to Rs 2,15,394.82 crore, following over one per cent rally in the stock at the BSE, overtaking SBI whose valuation stood at Rs 2,09,488.41 crore during the afternoon trade on Tuesday.

SBI's scrip was trading 0.48 per cent lower at Rs 280.30.